[{"Assets_0_FY_USD":4023690000.0,"CIK":"1048477","CommonStockSharesConverted_0_FY_shares":172647588.0,"CommonStockSharesOutstanding_0_FY_shares":172647588.0,"Country":"United States","EarningsPerShareBasic_4_FY_USD":-3.8,"EarningsPerShareDiluted_4_FY_USD":-3.81,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-227837000.0,"NetIncomeLossConverted_4_FY_USD":-630210000.0,"OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_4_FY_USD":1116854000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_FY_USD":2766275000.0,"Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":166219000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":165985000.0,"filed":"20170227","footnote":"nan","form":"10-K","fp":"FY","fy":"2016.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20161231","qtrs":"0","uom":"USD"}]